Hubei Jumpcan Pharmaceutical (600566.SH): Levofloxacin Granules Obtained Drug Registration Certificate.

Hubei Jumpcan Pharmaceutical (600566.SH) announced that its wholly-owned subsidiary, Hubei Jumpcan Pharmaceutical Group Co., Ltd., has received the drug registration certificate for levofloxacin granules issued by the National Medical Products Administration. Levofloxacin is a fluoroquinolone antibacterial drug developed by Daiichi Sankyo Co., Ltd. of Japan. It is a fourth-generation quinolone antibiotic that works by inhibiting the activity of bacterial DNA gyrase and topoisomerase IV. It has a wide spectrum of antibacterial activity against aerobic or anaerobic Gram-positive and Gram-negative bacteria, as well as atypical bacteria.